ACS-ZMØØ3-2
EU register of genetically modified food and feed.
| Event | T25 |
| Authorisation holder Name |
BASF Agricultural Solutions Seed US LLC Represented by BASF SE, Germany |
| Authorisation holder Address |
BASF Agricultural Solutions Seed US LLC, 100 Park Avenue, Florham Park, New Jersey 07932, United States of America
Represented by BASF SE, Carl-Bosch-Str. 38, D-67063 Ludwigshafen, Germany |
| Products |
1.) Foods and food ingredients containing, consisting of, or produced from ACS-ZMØØ3-2 maize 2.) Feed containing, consisting of, or produced from ACS-ZMØØ3-2 maize 3.) Products other than food and feed containing or consisting of ACS-ZMØØ3-2 maize for the same uses as any other maize with the exception of cultivation |
| Designation | The genetically modified ACS-ZMØØ3-2 maize, as described in the application, expresses the PAT protein which confers tolerance to glufosinate-ammonium herbicides. |
| Labelling |
1. For the purposes of the specific labelling requirements laid down in Article 13(1) and Article 25(2) of Regulation (EC) No 1829/2003, and in Article 4(6) of Regulation (EC) No 1830/2003, the ’name of the organism’ shall be ’maize’; 2. The words 'not for cultivation' shall appear on the label of and in documents accompanying products containing or consisting of ACS-ZMØØ3-2 maize with the exception of products referred to in point (a) of Article 2. |
| Method for detection |
An event-specific quantitative detection method for ACS-ZMØØ3-2 maize
Validated by the EU Reference Laboratory established under Regulation (EC) No 1829/2003, published at: URL: http://gmo-crl.jrc.ec.europa.eu/StatusOfDossiers.aspx |
| Reference material | AOCS 0306-H and AOCS 0306-C accessible via the American Oil Chemists Society at http://www.aocs.org/tech/crm/ |
| Unique identifier | ACS-ZMØØ3-2 |
| Annex II to the Cartagena Protocol | https://bch.cbd.int/database/record.shtml?documentid=108070 |
| Conditions or restrictions on the placing on the market | Not applicable |
| Monitoring plan | Monitoring plan for environmental effects conforming with Annex VII to Directive 2001/18/EC |
| Post-market monitoring requirements | Not appropriate |
| Date of authorisation | 24/04/2015 |
| Legal base |
Art. 11(3) and 23(3) of the Regulation (EC) No 1829/2003
Commission Decision 2015/697/UE of 24 April 2015
Amended by Commission Implementing Decision (EU) 2019/1195 of 10 July 2019 |
| Authorisation expiration date | 26/04/2025 |
| Further information on risk assessment |
Opinion of the European Food Safety Authority: http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2013-00761 |